MEDIGENE
Dead / Abandoned — Abandoned — no statement of use filed (as of 11 Apr 2022)
What this means for you
This application is over — abandoned 11 Apr 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88347854
- Mark type
- Design + words
- Filed
- 20 Mar 2019
- Published for opposition
- 12 Jan 2021
- Abandoned
- 11 Apr 2022
- Attorney of record
- ADRIENNE L. WHITE
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations, namely, cellular preparations for the treatment of tumours/neoplastic diseases, hematological tumors, more specifically leukemias or lymphomkas, solid tumors; Pharmaceutical T-cell preparations and dendritic cell preparations for the treatment of cancer and use in immunotherapy; medical compositions in the nature of pharmaceutical preparations for the treatment of hematological and solid tumors, tumor precursors; Test kits for diagnostic preparations for medical purposes for determining the type and/or existence of a tumor in a patient consisting primarily of soluble T-cell receptors; test kits for diagnostic preparations for medical purposes for determining the type and/or existence of a tumor in a patient consisting primarily of genetically modified cells; Test kits for diagnostic preparations for medical purposes for determining the type/existence of a tumor in a patient consisting of a composition of antibodies, soluble T-cell receptors and genetically modified cells; Diagnostic and therapeutic preparations for medical purposes being mixtures of therapeutically active cells in a suitable medium, in particular produced using molecular biological, biotechnological and genetic methods
- Class 042 — Scientific and technological services: Services in molecular biology, in particular research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, biotechnological and genetic methods, and in the field of screening for compounds with pharmaceutical properties; Development of test methods and test kits; Development of adoptive T cell therapy; Development of DC vaccines; Development of cellular tumour therapy; Development of tumour markers; Development of diagnostic and therapeutic antibodies
- Class 044 — Medical, beauty and agricultural services: Cell analyses in the nature of medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical and veterinary medical services, in particular extracting of blood and/or tissue samples and analysis and evaluation relating thereto; Individualized medicine in the nature of medical services; medical services specifically, development of treatment plans for the treatment of tumors and/or neoplastic diseases, hematopoietic tumors, solid tumors; physical therapy adapted for individual patients
Owner
- Medigene AG, Planegg-Martinsried, DE
- Medigene AG, Planegg-Martinsried, DE
Prior registrations
Prosecution history
- 11 Apr 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 11 Apr 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Sept 2021 — SOU EXTENSION 1 GRANTED
- 07 Sept 2021 — SOU EXTENSION 1 FILED
- 14 Sept 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Sept 2021 — SOU TEAS EXTENSION RECEIVED
- 09 Mar 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Jan 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Jan 2021 — PUBLISHED FOR OPPOSITION
- 23 Dec 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Dec 2020 — EXPARTE APPEAL TERMINATED
- 03 Dec 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Nov 2020 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 12 Sept 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED